# Tarsus Pharmaceuticals (stock symbol: TARS) Logo in transparent PNG and SVG formats

## Tarsus Pharmaceuticals Logo large

### Tarsus Pharmaceuticals Logo large Download PNG (32.51 KB)

![Tarsus Pharmaceuticals Logo large Download PNG (32.51 KB)](/img/orig/TARS_BIG-793e92cc.png)

### Tarsus Pharmaceuticals Logo large Download SVG (2.71 KB)

![Tarsus Pharmaceuticals Logo large Download SVG (2.71 KB)](/img/orig/TARS_BIG-71b68599.svg)

## Tarsus Pharmaceuticals Logo icon format

### Tarsus Pharmaceuticals Logo icon format Download PNG (58.86 KB)

![Tarsus Pharmaceuticals Logo icon format Download PNG (58.86 KB)](/img/orig/TARS-00152d44.png)

### Tarsus Pharmaceuticals Logo icon format Download SVG (1.36 KB)

![Tarsus Pharmaceuticals Logo icon format Download SVG (1.36 KB)](/img/orig/TARS-1819f1d7.svg)

## Tarsus Pharmaceuticals Logo large for dark backgrounds

### Tarsus Pharmaceuticals Logo large for dark backgrounds Download PNG (30.51 KB)

![Tarsus Pharmaceuticals Logo large for dark backgrounds Download PNG (30.51 KB)](/img/orig/TARS_BIG.D-e17bb0a1.png)

### Tarsus Pharmaceuticals Logo large for dark backgrounds Download SVG (2.8 KB)

![Tarsus Pharmaceuticals Logo large for dark backgrounds Download SVG (2.8 KB)](/img/orig/TARS_BIG.D-7af08145.svg)

## Tarsus Pharmaceuticals Logo icon format for dark backgrounds

### Tarsus Pharmaceuticals Logo icon format for dark backgrounds Download PNG (55.96 KB)

![Tarsus Pharmaceuticals Logo icon format for dark backgrounds Download PNG (55.96 KB)](/img/orig/TARS.D-c2ff3984.png)

### Tarsus Pharmaceuticals Logo icon format for dark backgrounds Download SVG (1.26 KB)

![Tarsus Pharmaceuticals Logo icon format for dark backgrounds Download SVG (1.26 KB)](/img/orig/TARS.D-9cd7a41d.svg)

## About Tarsus Pharmaceuticals

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

1. Website domain: tarsusrx.com
2. Employees: 46
3. Marketcap: $0.39 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
